MAPK3 and depressive symptom measurement: Intracellular signaling pathways in the brain involving ERK1/2, GSK3β and mammalian/mechanistic target of rapamycin (mTOR) have been implicated in depression in humans [49–51] and in antidepressant response in animal models [52–54].